STOCK TITAN
  1. Home
  2. Sec-filings
  3. BMY
  4. [Form 4] BRISTOL MYERS SQUIBB CO Insider Trading Activity

[Form 4] BRISTOL MYERS SQUIBB CO Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock BMY logo
Bristol-Myers Squibb Co

NYSE:BMY

BMY Rankings

#161 Ranked by Market Cap
#636 Ranked by Dividends

BMY Latest News

Oct 13, 2025
Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types
Oct 13, 2025
SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration
Oct 10, 2025
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
Oct 10, 2025
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection
Oct 1, 2025
Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease

BMY Latest SEC Filings

Oct 6, 2025
[Form 4] BRISTOL MYERS SQUIBB CO Insider Trading Activity
Oct 2, 2025
[Form 4] BRISTOL MYERS SQUIBB CO Insider Trading Activity
Oct 2, 2025
[Form 4] BRISTOL MYERS SQUIBB CO Insider Trading Activity
Oct 2, 2025
[Form 4] BRISTOL MYERS SQUIBB CO Insider Trading Activity
Sep 3, 2025
[Form 4] Bristol-Myers Squibb Co. Insider Trading Activity

BMY Stock Data

89.48B
2.03B
0.07%
82.82%
1.53%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
PRINCETON